Older breast cancer patients in England less likely to survive than in four other European countries
Older women diagnosed with breast cancer in England are less likely to survive their disease than those in Belgium, Poland, Ireland and the Netherlands.
A test that measures gene activity can help tailor treatment for some women with early stage breast cancer, sparing them chemotherapy.
Six months of breast cancer treatment ‘could be as effective as 12’ in some women with early stage disease
Six months of treatment could be as effective as 12 months for women with a type of early stage breast cancer, according to unpublished clinical trial results.
In the immediate aftermath, estimating the numbers affected by a breast screening error might do more harm than good.
Around 450,000 women in England missed out on a routine breast screening appointment due to an NHS failure to send invitations.
Aggressive breast cancers carrying a faulty BRCA gene responded better to a certain type of chemotherapy than standard treatment, according to a trial.
Six in seven women with a family history of breast cancer opt out of taking tamoxifen as a preventative measure, according to a study.
With new cancer detection technology on the horizon, ranging from blood tests to wristbands, understanding overdiagnosis is a huge challenge.
Our researchers have discovered a way to halt breast cancer spread in mice, by blocking a molecule called asparagine. But what does this mean for patients?